SF3B1 mutations, which are prevalent in myelodysplastic syndrome (MDS) and leukemia, result in missplicing of Brd9 and a subsequent loss of ncBAF at CTCF-associated loci [67]. Here, SF3B1 is linked to myelodysplastic syndrome.